Friday, 25 September 2026European Markets

SPORTING Stock 9.83% Up Before The Weekend

Loading stream...

(VIANEWS) - The Market ended the session with SPORTING (SCP.LS) rising 9.83% to €0.95 on Friday, following the last session's upward trend. PSI slid 1.13% to €6,737.11, after three successive sessions in a row of losses, on what was an all-around bearish trend trading session today.

SPORTING's last close was €0.87, 8.95% under its 52-week high of €0.95.

About SPORTING

Sporting Clube de Portugal - Futebol, SAD operates sports clubs in Portugal. The company also engages in the sale of tickets for games; advertising and sponsorships activities; and provision of television rights. Sporting Clube de Portugal - Futebol, SAD was founded in 1907 and is headquartered in Lisbon, Portugal.

Earnings Per Share

As for profitability, SPORTING has a trailing twelve months EPS of €0.18.

PE Ratio

SPORTING has a trailing twelve months price to earnings ratio of 5.28. Meaning, the purchaser of the share is investing €5.28 for every euro of annual earnings.

Volume

Today's last reported volume for SPORTING is 98 which is 93.76% below its average volume of 1571.

Yearly Top and Bottom Value

SPORTING's stock is valued at €0.95 at 22:30 EST, way under its 52-week low of €0.65.

More news about SPORTING (SCP.LS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com